Sfoglia per AUTORE
LEIGHL NB
Collezione AOU San Luigi di Orbassano
Items : 2
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Oct 20;42(30):3593-3605. doi: 10.1200/JCO.24.01001. Epub 2024 Jun 10.
2024
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Leighl NB; Akamatsu H; Lim SM; Cheng Y; Minchom AR; Marmarelis ME; Sanborn RE; Chih-Hsin Yang J; Liu B; John T; Massutí B; Spira AI; Lee SH; Wang J; Li J; Liu C; Novello S; Kondo M; Tamiya M; Korbenfeld E; Moskovitz M; Han JY; Alexander M; Joshi R; Felip E; Voon PJ; Danchaivijitr P; Hsu PC; Silva Melo Cruz FJ; et alii...
Scientific Advances in Thoracic Oncology 2016. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1.
2017
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Soo RA; Stone ECA; Cummings KM; Jett JR; Field JK; Groen HJM; Mulshine JL; Yatabe Y; Bubendorf L; Dacic S; Rami-Porta R; Detterbeck FC; Lim E; Asamura H; Donington J; Wakelee HA; Wu YL; Higgins K; Senan S; Solomon B; Kim DW; Johnson M; Yang JCH; Sequist LV; Shaw AT; Ahn MJ; Costa DB; Patel JD; Horn L; et alii...